Alliance Pharma PLC
LSE:APH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alliance Pharma PLC
LSE:APH
|
UK |
|
Orkla ASA
F:OKL0
|
NO |
|
C
|
Coles Group Ltd
F:2OF
|
AU |
|
C
|
Cal-Maine Foods Inc
F:CM2
|
US |
|
BizLink Holding Inc
TWSE:3665
|
US |
|
Universal Corp
NYSE:UVV
|
US |
|
E
|
EVN AG
VSE:EVN
|
AT |
|
Silvercrest Asset Management Group Inc
NASDAQ:SAMG
|
US |
|
Majestic Gold Corp
XTSX:MJS
|
CA |
|
Relief Therapeutics Holding SA
SIX:RLF
|
CH |
|
Seadrill Ltd
OSE:SDRL
|
BM |
|
Public Bank Bhd
KLSE:PBBANK
|
MY |
|
Somero Enterprises Inc
LSE:SOM
|
US |
|
P
|
PGE Polska Grupa Energetyczna SA
SWB:6PG
|
PL |
|
N
|
Nissei Plastic Industrial Co Ltd
TSE:6293
|
JP |
|
Ion Energy Ltd
XTSX:ION
|
CA |
Bankruptcy Probability
Alliance Pharma PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Alliance Pharma PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
A
|
Alliance Pharma PLC
LSE:APH
|
349.7m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
208.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
334.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Alliance Pharma PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Alliance Pharma PLC has total debt of 95.1m GBP. This includes both short-term (0 GBP) and long-term (95.1m GBP) debt.
You can find a full breakdown on its Balance Sheet.
